Date search

Top news

  • NovaMedica Launches Own Innovative Drug for the Treatment of Alzheimers Disease


    Russian pharmaceutical company NovaMedica (investment project of RUSNANO) has developed and registered an innovative combination of Donepezil and Memantine molecules, which are the basic therapy for dementia associated with Alzheimer's disease. The drug is registered under the name MIOREOL®. This is the first such combination in the Russian market and in the markets of the EAEU and Europe.

  • NovaMedica signed an agreement with Bayer on transfer of exclusive rights to its product


    Russian pharmaceutical company NovaMedica (part of the RUSNANO portfolio) and the corporation Bayer signed an agreement to provide Bayer with an exclusive license to commercialization of an innovative product developed by NovaMedica, including its manufacturing and promotion.

Read more

Media about us

All publications

Our news

All news

Industry news

All industry news